CeriBell (CBLL) Competitors $17.76 +0.04 (+0.23%) Closing price 04:00 PM EasternExtended Trading$17.76 0.00 (0.00%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. LIVN, WRBY, NVCR, LMAT, ENOV, CNMD, EYE, LQDA, CDRE, and TNDMShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), CONMED (CNMD), National Vision (EYE), Liquidia (LQDA), Cadre (CDRE), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. CeriBell vs. Its Competitors LivaNova Warby Parker NovoCure LeMaitre Vascular Enovis CONMED National Vision Liquidia Cadre Tandem Diabetes Care LivaNova (NASDAQ:LIVN) and CeriBell (NASDAQ:CBLL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership. Does the MarketBeat Community believe in LIVN or CBLL? LivaNova received 399 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 69.80% of users gave LivaNova an outperform vote. CompanyUnderperformOutperformLivaNovaOutperform Votes40969.80% Underperform Votes17730.20% CeriBellOutperform Votes10100.00% Underperform VotesNo Votes Which has preferable earnings & valuation, LIVN or CBLL? LivaNova has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.28B2.02$17.55M-$4.09-11.56CeriBell$71.54M8.80N/AN/AN/A Does the media prefer LIVN or CBLL? In the previous week, CeriBell had 1 more articles in the media than LivaNova. MarketBeat recorded 6 mentions for CeriBell and 5 mentions for LivaNova. CeriBell's average media sentiment score of 1.10 beat LivaNova's score of 0.35 indicating that CeriBell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral CeriBell 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is LIVN or CBLL more profitable? LivaNova has a net margin of 1.91% compared to CeriBell's net margin of 0.00%. LivaNova's return on equity of 13.81% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets LivaNova1.91% 13.81% 7.07% CeriBell N/A N/A N/A Do institutionals & insiders have more ownership in LIVN or CBLL? 97.6% of LivaNova shares are owned by institutional investors. 0.3% of LivaNova shares are owned by insiders. Comparatively, 20.1% of CeriBell shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate LIVN or CBLL? LivaNova currently has a consensus price target of $59.29, indicating a potential upside of 25.34%. CeriBell has a consensus price target of $32.50, indicating a potential upside of 86.51%. Given CeriBell's higher possible upside, analysts clearly believe CeriBell is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryLivaNova and CeriBell tied by winning 7 of the 14 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$629.86M$3.38B$5.60B$8.65BDividend YieldN/A1.76%5.27%4.19%P/E RatioN/A18.4327.3320.13Price / Sales8.80211.63412.21156.99Price / CashN/A44.0938.2534.64Price / BookN/A3.957.154.74Net IncomeN/A$94.03M$3.23B$247.88M7 Day Performance1.66%2.89%3.49%2.64%1 Month Performance9.11%14.62%12.92%9.95%1 Year PerformanceN/A25.34%32.15%15.33% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell2.4373 of 5 stars$17.76+0.2%$32.50+83.0%N/A$641.90M$71.54M0.00N/APositive NewsLIVNLivaNova2.7833 of 5 stars$46.30+0.8%$59.29+28.0%-9.9%$2.52B$1.28B110.242,900Positive NewsWRBYWarby Parker2.025 of 5 stars$22.47+4.1%$22.88+1.8%+31.7%$2.35B$795.09M-83.243,030Positive NewsNVCRNovoCure3.6944 of 5 stars$16.90-0.6%$32.83+94.3%-14.4%$1.88B$621.71M-12.071,320LMATLeMaitre Vascular2.9015 of 5 stars$83.32-1.0%$97.83+17.4%+7.7%$1.88B$226.26M45.53490Positive NewsENOVEnovis2.3839 of 5 stars$32.94+3.6%$58.00+76.1%-25.7%$1.88B$2.15B-15.046,800High Trading VolumeCNMDCONMED4.0294 of 5 stars$59.05+3.7%$62.20+5.3%-20.2%$1.83B$1.32B13.934,100EYENational Vision3.2426 of 5 stars$21.01-0.1%$17.75-15.5%+46.7%$1.66B$1.85B-105.0414,000Positive NewsLQDALiquidia3.7586 of 5 stars$18.02-0.7%$26.67+48.0%+8.2%$1.54B$14.14M-11.0650Analyst ForecastOptions VolumeGap UpCDRECadre2.3619 of 5 stars$35.08+1.7%$37.00+5.5%+7.1%$1.43B$559.81M42.272,240Positive NewsTNDMTandem Diabetes Care4.0329 of 5 stars$20.23-2.6%$35.86+77.2%-53.7%$1.35B$982.95M-10.482,600Positive News Related Companies and Tools Related Companies LivaNova Alternatives Warby Parker Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives Enovis Alternatives CONMED Alternatives National Vision Alternatives Liquidia Alternatives Cadre Alternatives Tandem Diabetes Care Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLL Stock Free CBLL Stock Alerts